loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of All Manufacturers & Suppliers for 206352 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

    Client Virtual Booth
    Menu

    Bristol Myers Squibb

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 ATAZANAVIR SULFATE (1)

    filter

    01 BRISTOL MYERS SQUIBB (1)

    filter

    01 POWDER;ORAL (1)

    filter

    01 EQ 50MG BASE/PACKET (1)

    filter

    01 USA (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Atazanavir Sulfate

    PDF Supplier PDF
    URL Supplier Web Content
    POWDER;ORAL
    EQ 50MG BASE/PACKET
    REYATAZ
    USA
    206352
    2014-06-02
    RX
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for CTD TGA MCC DOSSIER APPLICATION 206352

    Looking for CTD TGA MCC DOSSIER APPLICATION 206352 1

    19

    Bristol Myers Squibb, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    One of their notable products is ATAZANAVIR SULFATE, with a corresponding application number 206352 and regulatory information .

    proudly manufactured in the

    approval since 2014-06-02

    Bristol Myers Squibb's REYATAZ POWDER;ORAL, medication with EQ 50MG BASE/PACKET of ATAZANAVIR SULFATE.

    Post Enquiry
    POST ENQUIRY